mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
0.19 |
0.2 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.2 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.069 |
0.2 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.3 |